Summary: Guidance Document- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy
Données et ressources
Info additionnelle
| Champ | Valeur |
|---|---|
| Dernière modification | avril 17, 2026, 21:39 (TU) |
| Créé le | avril 17, 2026, 21:39 (TU) |
| criticality_level | [] |
| geographic_scope | [] |
| open_canada_collection | publication |
| open_canada_date_published | 2021-05-26 00:00:00 |
| open_canada_keywords | {"fr": ["document d'orientation", "sommaire", "modifications post-avis de conformité", "innocuité et efficacité", "cadre", "innocuité et efficacité", "sur la qualité", "aux nouveaux", "médicaments"], "en": ["summary guidance document", "post-notice of-compliance-changes", "safety-and-efficacy", "framework", "safety-and-efficacy", "quality guidance documents", "post-approval changes to-new-drugs"]} |
| open_canada_subject | ["health_and_safety"] |
| sensitivity_level | unrestricted |
| title_fr | Sommaire : Ligne directrice - Changements survenus après l'avis de conformité (AC) : Document sur l’innocuité et efficacité |
| update_frequency | as_needed |